Novo Nordisk has launched a once-daily Wegovy pill, marking the first oral GLP-1 medication approved for weight loss in the U.S. According to reports, this development provides an alternative to injectable treatments, which have seen significant demand. The Wegovy pill aims to broaden access to GLP-1 weight-loss drugs, offering a new option for individuals seeking treatment.

Novo Nordisk has launched a once-daily Wegovy pill, marking the first oral GLP-1 medication approved for weight loss in the U.S. According to reports, this development provides an alternative to injectable treatments, which have seen significant demand. The Wegovy pill aims to broaden access to GLP-1 weight-loss drugs, offering a new option for individuals seeking treatment.